LU91085B1 - Radionuclides for medical use. - Google Patents

Radionuclides for medical use.

Info

Publication number
LU91085B1
LU91085B1 LU91085A LU91085A LU91085B1 LU 91085 B1 LU91085 B1 LU 91085B1 LU 91085 A LU91085 A LU 91085A LU 91085 A LU91085 A LU 91085A LU 91085 B1 LU91085 B1 LU 91085B1
Authority
LU
Luxembourg
Prior art keywords
radionuclides
medical use
medical
Prior art date
Application number
LU91085A
Inventor
Christos Apostolidis
Klaus Luetzenkirchen
Roger Molinet
Alfred Morgenstern
Original Assignee
European Community
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by European Community filed Critical European Community
Priority to LU91085A priority Critical patent/LU91085B1/en
Priority to EP05774045.8A priority patent/EP1763372B1/en
Priority to EP11183364.6A priority patent/EP2497501B1/en
Priority to AU2005259258A priority patent/AU2005259258B2/en
Priority to CA2570191A priority patent/CA2570191C/en
Priority to PCT/EP2005/052966 priority patent/WO2006003123A2/en
Application granted granted Critical
Publication of LU91085B1 publication Critical patent/LU91085B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
LU91085A 2004-06-25 2004-06-25 Radionuclides for medical use. LU91085B1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
LU91085A LU91085B1 (en) 2004-06-25 2004-06-25 Radionuclides for medical use.
EP05774045.8A EP1763372B1 (en) 2004-06-25 2005-06-24 Radionuclides for medical use
EP11183364.6A EP2497501B1 (en) 2004-06-25 2005-06-24 Radionuclides for medical use
AU2005259258A AU2005259258B2 (en) 2004-06-25 2005-06-24 Radionuclides for medical use
CA2570191A CA2570191C (en) 2004-06-25 2005-06-24 Radionuclides for medical use
PCT/EP2005/052966 WO2006003123A2 (en) 2004-06-25 2005-06-24 Radionuclides for medical use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU91085A LU91085B1 (en) 2004-06-25 2004-06-25 Radionuclides for medical use.

Publications (1)

Publication Number Publication Date
LU91085B1 true LU91085B1 (en) 2005-12-27

Family

ID=34955594

Family Applications (1)

Application Number Title Priority Date Filing Date
LU91085A LU91085B1 (en) 2004-06-25 2004-06-25 Radionuclides for medical use.

Country Status (1)

Country Link
LU (1) LU91085B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028450A1 (en) * 1997-12-01 1999-06-10 Lockheed Martin Energy Research Corporation Method for facilitating the introduction of material into cells or structures
US5922302A (en) * 1993-05-17 1999-07-13 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
WO2002005859A2 (en) * 2000-07-04 2002-01-24 Anticancer Therapeutic Inventions As Radiotherapy
US20020058007A1 (en) * 2000-09-15 2002-05-16 David Scheinberg Targeted alpha particle therapy using actinium-225 conjugates

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922302A (en) * 1993-05-17 1999-07-13 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
WO1999028450A1 (en) * 1997-12-01 1999-06-10 Lockheed Martin Energy Research Corporation Method for facilitating the introduction of material into cells or structures
WO2002005859A2 (en) * 2000-07-04 2002-01-24 Anticancer Therapeutic Inventions As Radiotherapy
US20020058007A1 (en) * 2000-09-15 2002-05-16 David Scheinberg Targeted alpha particle therapy using actinium-225 conjugates

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PAGEL J M ET AL: "The use of radioimmunoconjugates in stem cell transplantation.", BONE MARROW TRANSPLANTATION. MAY 2002, vol. 29, no. 10, May 2002 (2002-05-01), pages 807 - 816, XP002320204, ISSN: 0268-3369 *

Similar Documents

Publication Publication Date Title
GB2427362B (en) Imaging catheter
GB0420676D0 (en) Medical device
EP1871222A4 (en) User interface improvements for medical devices
IL219642A0 (en) Catheter
GB0403947D0 (en) Patient records system
HUE054365T2 (en) Boronophthalides for therapeutic use
EP1787673A4 (en) Catheter
EP1738735A4 (en) Medical bed
EP1937199A4 (en) Medical device
EP1806119A4 (en) Medicine cart
IL180487A0 (en) Medicament
GB0420411D0 (en) Medical device
GB0415195D0 (en) Syringe
LU91085B1 (en) Radionuclides for medical use.
GB2415909B (en) Medical Aid
GB2421687B8 (en) Medical device
GB0418462D0 (en) Medical device
GB0417339D0 (en) Syringe
PL114821U1 (en) Coffin
GB2413766B (en) Medical device
GB0409098D0 (en) Medicament
GB0426942D0 (en) Medicament
GB0403149D0 (en) Medicament
ZA200604785B (en) Medical claims
ZA200408968B (en) Safe syringe.